Global Label-free Array Systems: Overview
Label-free array systems are used in the drug discovery industry by pharmaceutical and biotechnology companies, and work on the principles of optical interferometry, refractive index, and impedance based assays, for the identification and validation of the new molecules as the possible drug candidates, without the use of any labels, in real time and high throughput, thus reducing the time and cost of the drug identification and validation process. This report studies the current scenario as well as future market potential for label-free array systems globally.
The market overview section of the report comprises qualitative analysis of the overall label-free array systems market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.
Global Label-free Array Systems: Segmentation
The global label-free array systems market has been segmented on the basis of technology, applications and end users. On the basis of technology the global label-free array systems market is further segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. The applications have been further segmented into drug discovery, antibody characterization and development, protein interface analysis, protein complex and cascade analysis, and other applications.
On the basis of end users, the global label-free array systems market is segmented into R&D laboratories, contract research organizations, agriculture research institutes among others. The market for these technologies, end users and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (US$ million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.
Global Label-free Array Systems: Regional Outlook
Geographically, the label-free array systems market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2016 to 2024.
Key players Mentioned in this Report are:
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global label-free array systems market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global label-free array systems market such as Biacore, Agilent technologies, Molecular Devices, Perkin Elmer, Attana AB, BiOptix, Inc., GWC Technologies, ForteBio, F. Hoffman LA Roche. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
Global Label-Free Array Systems Market is segmented as follows:
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote